Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fluvoxamine potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]		 NA approved,investigational unknown
fluvoxamine potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
fluvoxamine serotonin transporter NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]		 1.08 approved unknown
fluvoxamine sodium-dependent serotonin transporter small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]		 1.08 approved,investigational inhibitor
fluvoxamine sodium-dependent serotonin transporter small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.08 approved,investigational inhibitor
fluvoxamine serotonin transporter NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.08 approved inhibitor
fluvoxamine serotonin transporter NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.08 approved unknown
fluvoxamine serotonin transporter NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Depressive disorder[MeSHID:D003866]
Bulimia Nervosa[MeSHID:D052018]
Mental Depression[MeSHID:D003863]
Obsessive compulsive behavior[MeSHID:D003192]
Obsessive-Compulsive Disorder[MeSHID:D009771]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]
Coronavirus Infections[MeSHID:D018352]		 1.08 approved inhibitor
click here to return to the previous page